Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotype

Author:

Sarli Camilla1ORCID,van der Laan Liselot2ORCID,Reilly Jack3ORCID,Trajkova Slavica45ORCID,Carli Diana4ORCID,Brusco Alfredo467ORCID,Levy Michael A.8,Relator Raissa8ORCID,Kerkhof Jennifer8ORCID,McConkey Haley38,Tedder Matthew L.9ORCID,Skinner Cindy9ORCID,Alders Mariëlle2ORCID,Henneman Peter2ORCID,Hennekam Raoul C. M.2,Ciaccio Claudia10ORCID,D'Arrigo Stefano10ORCID,Vitobello Antonio11ORCID,Faivre Laurence1213ORCID,Weber Sacha1415ORCID,Vincent‐Devulder Aline11,Perrin Laurence11,Bourgois Alexia11,Yamamoto Toshiyuki16ORCID,Metcalfe Kay1718,Zollino Marcella1920,Kini Usha21,Oliveira Daniela22,Sousa Sergio B.22,Williams Denise23,Cappuccio Gerarda1ORCID,Sadikovic Bekim238,Brunetti‐Pierri Nicola12425ORCID

Affiliation:

1. Department of Translational Medicine Federico II University of Naples Naples Italy

2. Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers University of Amsterdam Amsterdam The Netherlands

3. Department of Pathology and Laboratory Medicine Western University London Ontario Canada

4. Department of Medical Sciences University of Torino Turin Italy

5. Molecular Biotechnology Center “Guido Tarone” University of Turin Turin Italy

6. Medical Genetics Unit Città della Salute e della Scienza University Hospital Turin Italy

7. Department of Neurosciences Rita Levi‐Montalcini University of Turin Turin Italy

8. Verspeeten Clinical Genome Centre London Health Science Centre London Ontario Canada

9. Greenwood Genetic Center Greenwood South Carolina USA

10. Department of Pediatric Neurosciences Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy

11. Department of Genetics, UNICAEN, Caen University Hospital Normandy University Caen France

12. Université de Bourgogne, Inserm U1231, Equipe GAD Dijon France

13. CHU Dijon Bourgogne, Centre de Génétique Centre de Référence Maladies Rares “Anomalies du Développement et Syndromes Malformatifs”, FHU‐TRANSLDAD Dijon France

14. Service de Génétique CHU de Caen‐Normandie Caen France

15. Service de Neurologie CHU de Caen‐Normandie Caen France

16. Division of Gene Medicine, Graduate School of Medical Science Tokyo Women's Medical University Tokyo Japan

17. Manchester Centre for Genomic Medicine, St Mary's Hospital, Health Innovation Manchester Manchester University Foundation NHS Trust Manchester UK

18. Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health The University of Manchester Manchester UK

19. Institute of Genomic Medicine, Department of Life Sciences and Public Health 'Sacro Cuore' Catholic University of Rome Rome Italy

20. Medical Genetics Unit Foundation IRCCS AOU Policlinico ‘A. Gemelli’ Rome Italy

21. Oxford Centre for Genomic Medicine Oxford University Hospitals NHS Foundation Trust Oxford UK

22. Medical Genetics Unit, Hospital Pediátrico Centro Hospitalar e Universitário de Coimbra Coimbra Portugal

23. Department of Clinical Genetics Birmingham Women's & Children's NHS Foundation Trust Birmingham UK

24. Telethon Institute of Genetics and Medicine Pozzuoli Italy

25. Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program University of Naples Federico II Naples Italy

Abstract

AbstractBlepharophimosis with intellectual disability (BIS) is a recently recognized disorder distinct from Nicolaides‐Baraister syndrome that presents with distinct facial features of blepharophimosis, developmental delay, and intellectual disability. BIS is caused by pathogenic variants in SMARCA2, that encodes the catalytic subunit of the superfamily II helicase group of the BRG1 and BRM‐associated factors (BAF) forming the BAF complex, a chromatin remodeling complex involved in transcriptional regulation. Individuals bearing variants within the bipartite nuclear localization (BNL) signal domain of ADNP present with the neurodevelopmental disorder known as Helsmoortel‐Van Der Aa Syndrome (HVDAS). Distinct DNA methylation profiles referred to as episignatures have been reported in HVDAS and BAF complex disorders. Due to molecular interactions between ADNP and BAF complex, and an overlapping craniofacial phenotype with narrowing of the palpebral fissures in a subset of patients with HVDAS and BIS, we hypothesized the possibility of a common phenotype‐specific episignature. A distinct episignature was shared by 15 individuals with BIS‐causing SMARCA2 pathogenic variants and 12 individuals with class II HVDAS caused by truncating pathogenic ADNP variants. This represents first evidence of a sensitive phenotype‐specific episignature biomarker shared across distinct genetic conditions that also exhibit unique gene‐specific episignatures.

Funder

Fondazione Telethon

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3